Skip to main content

Table 1 Clinical and laboratory characteristics of the patients in the study

From: Systemic lupus erythematosus dysregulates the expression of long noncoding RNAs in placentas

Characteristics

SLE (n = 10)

NT (n = 10)

P

Age (years), median (range)

29.0 (26–36)

30.5 (28–33)

> 0.05

BMI, median (range)

25.4 (23.0–32.3)

28.0 (21.8–32.7)

> 0.05

Gestation age (weeks), median (range)

38.5 (34.9–39.7)

39.1 (38.6–40.1)

< 0.05

Fetal weight (grams), median (range)

2950.0 (2150.0–3850.0)

3402.0 (2895.0–3730.0)

< 0.05

Fetal weight lower than 10th percentile (%)

10

0

> 0.05

Vaginal delivery (n)

8

8

> 0.05

Disease duration (months), median (range)

40.0 (10–167)

–

–

SLEDAI score, median (range)

2.5 (0–6)

–

–

ANA > 1:320, yes/no (n)

10/0

–

–

Anti-dsDNA, yes/no (n)

2/8

–

–

Anti-phospholipid, yes/no (n)

3/7

–

–

Preeclampsia, yes/no (n)

0/8

–

–

Proteinuria, yes/no (n)

3/7

–

–

Hypocomplementemia, yes/no (n)

3/7

–

–

Steroids, yes/no (n)

10/0

–

–

Immunosuppressive drugs, yes/no (n)

0/10

–

–

Aspirin, yes/no (n)

3/7

–

–

  1. SLE systemic lupus erythematosus, NT normal term, BMI body mass index, SLEDAI systemic lupus erythematosus disease activity index, ANA antinuclear antibody